Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults

PURPOSE: Recent advances in nonmyeloablative (NMA), related HLA-haploidentical blood or marrow transplantation (haplo-BMT) have expanded the donor pool. This study evaluated the effect of age on NMA haplo-BMT outcomes in patients age 50 to 75 years. PATIENTS AND METHODS: A retrospective analysis was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Kasamon, Yvette L., Bolaños-Meade, Javier, Prince, Gabrielle T., Tsai, Hua-Ling, McCurdy, Shannon R., Kanakry, Jennifer A., Rosner, Gary L., Brodsky, Robert A., Perica, Karlo, Smith, B. Douglas, Gladstone, Douglas E., Swinnen, Lode J., Showel, Margaret M., Matsui, William H., Huff, Carol Ann, Borrello, Ivan, Pratz, Keith W., McDevitt, Michael A., Gojo, Ivana, Dezern, Amy E., Shanbhag, Satish, Levis, Mark J., Luznik, Leo, Ambinder, Richard F., Fuchs, Ephraim J., Jones, Richard J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2015
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4582145/
https://ncbi.nlm.nih.gov/pubmed/26261255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.60.4777
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados